201 related articles for article (PubMed ID: 21779896)
1. Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization.
Pickens SR; Chamberlain ND; Volin MV; Gonzalez M; Pope RM; Mandelin AM; Kolls JK; Shahrara S
Angiogenesis; 2011 Dec; 14(4):443-55. PubMed ID: 21779896
[TBL] [Abstract][Full Text] [Related]
2. CXCR2-specific chemokines mediate leukotriene B4-dependent recruitment of neutrophils to inflamed joints in mice with antigen-induced arthritis.
Grespan R; Fukada SY; Lemos HP; Vieira SM; Napimoga MH; Teixeira MM; Fraser AR; Liew FY; McInnes IB; Cunha FQ
Arthritis Rheum; 2008 Jul; 58(7):2030-40. PubMed ID: 18576322
[TBL] [Abstract][Full Text] [Related]
3. A distinct regulatory role of Th17 cytokines IL-17A and IL-17F in chemokine secretion from lung microvascular endothelial cells.
Fujie H; Niu K; Ohba M; Tomioka Y; Kitazawa H; Nagashima K; Ohrui T; Numasaki M
Inflammation; 2012 Jun; 35(3):1119-31. PubMed ID: 22219048
[TBL] [Abstract][Full Text] [Related]
4. IL-17A and TNF-α exert synergistic effects on expression of CXCL5 by alveolar type II cells in vivo and in vitro.
Liu Y; Mei J; Gonzales L; Yang G; Dai N; Wang P; Zhang P; Favara M; Malcolm KC; Guttentag S; Worthen GS
J Immunol; 2011 Mar; 186(5):3197-205. PubMed ID: 21282514
[TBL] [Abstract][Full Text] [Related]
5. PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer.
Keshamouni VG; Arenberg DA; Reddy RC; Newstead MJ; Anthwal S; Standiford TJ
Neoplasia; 2005 Mar; 7(3):294-301. PubMed ID: 15799829
[TBL] [Abstract][Full Text] [Related]
6. Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model.
Connolly M; Marrelli A; Blades M; McCormick J; Maderna P; Godson C; Mullan R; FitzGerald O; Bresnihan B; Pitzalis C; Veale DJ; Fearon U
J Immunol; 2010 Jun; 184(11):6427-37. PubMed ID: 20435930
[TBL] [Abstract][Full Text] [Related]
7. A crucial role for TNF-alpha in mediating neutrophil influx induced by endogenously generated or exogenous chemokines, KC/CXCL1 and LIX/CXCL5.
Vieira SM; Lemos HP; Grespan R; Napimoga MH; Dal-Secco D; Freitas A; Cunha TM; Verri WA; Souza-Junior DA; Jamur MC; Fernandes KS; Oliver C; Silva JS; Teixeira MM; Cunha FQ
Br J Pharmacol; 2009 Oct; 158(3):779-89. PubMed ID: 19702783
[TBL] [Abstract][Full Text] [Related]
8. CXCR2 is essential for cerebral endothelial activation and leukocyte recruitment during neuroinflammation.
Wu F; Zhao Y; Jiao T; Shi D; Zhu X; Zhang M; Shi M; Zhou H
J Neuroinflammation; 2015 May; 12():98. PubMed ID: 25990934
[TBL] [Abstract][Full Text] [Related]
9. Duffy antigen receptor for chemokines and CXCL5 are essential for the recruitment of neutrophils in a multicellular model of rheumatoid arthritis synovium.
Smith E; McGettrick HM; Stone MA; Shaw JS; Middleton J; Nash GB; Buckley CD; Ed Rainger G
Arthritis Rheum; 2008 Jul; 58(7):1968-73. PubMed ID: 18576313
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis.
Haas CS; Amin MA; Allen BB; Ruth JH; Haines GK; Woods JM; Koch AE
Arthritis Rheum; 2006 Aug; 54(8):2402-14. PubMed ID: 16869003
[TBL] [Abstract][Full Text] [Related]
11. Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways.
Liu C; He L; Wang J; Wang Q; Sun C; Li Y; Jia K; Wang J; Xu T; Ming R; Wang Q; Lin N
J Ethnopharmacol; 2020 Oct; 260():113039. PubMed ID: 32497675
[TBL] [Abstract][Full Text] [Related]
12. IL-17A promotes the exacerbation of IL-33-induced airway hyperresponsiveness by enhancing neutrophilic inflammation via CXCR2 signaling in mice.
Mizutani N; Nabe T; Yoshino S
J Immunol; 2014 Feb; 192(4):1372-84. PubMed ID: 24446518
[TBL] [Abstract][Full Text] [Related]
13. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis.
Numasaki M; Watanabe M; Suzuki T; Takahashi H; Nakamura A; McAllister F; Hishinuma T; Goto J; Lotze MT; Kolls JK; Sasaki H
J Immunol; 2005 Nov; 175(9):6177-89. PubMed ID: 16237115
[TBL] [Abstract][Full Text] [Related]
14. CXCL1 stimulates decidual angiogenesis via the VEGF-A pathway during the first trimester of pregnancy.
Ma C; Liu G; Liu W; Xu W; Li H; Piao S; Sui Y; Feng W
Mol Cell Biochem; 2021 Aug; 476(8):2989-2998. PubMed ID: 33770315
[TBL] [Abstract][Full Text] [Related]
15. CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer.
Chen C; Xu ZQ; Zong YP; Ou BC; Shen XH; Feng H; Zheng MH; Zhao JK; Lu AG
Cell Death Dis; 2019 Feb; 10(3):178. PubMed ID: 30792394
[TBL] [Abstract][Full Text] [Related]
16. Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint.
Koch AE; Volin MV; Woods JM; Kunkel SL; Connors MA; Harlow LA; Woodruff DC; Burdick MD; Strieter RM
Arthritis Rheum; 2001 Jan; 44(1):31-40. PubMed ID: 11212173
[TBL] [Abstract][Full Text] [Related]
17. Tumour tissue microenvironment can inhibit dendritic cell maturation in colorectal cancer.
Michielsen AJ; Hogan AE; Marry J; Tosetto M; Cox F; Hyland JM; Sheahan KD; O'Donoghue DP; Mulcahy HE; Ryan EJ; O'Sullivan JN
PLoS One; 2011; 6(11):e27944. PubMed ID: 22125641
[TBL] [Abstract][Full Text] [Related]
18. The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells.
Thobe MN; Gurusamy D; Pathrose P; Waltz SE
Oncogene; 2010 Jan; 29(2):214-26. PubMed ID: 19838218
[TBL] [Abstract][Full Text] [Related]
19. Human Brain Endothelial CXCR2 is Inflammation-Inducible and Mediates CXCL5- and CXCL8-Triggered Paraendothelial Barrier Breakdown.
Haarmann A; Schuhmann MK; Silwedel C; Monoranu CM; Stoll G; Buttmann M
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704100
[TBL] [Abstract][Full Text] [Related]
20. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
